Review

Polypharmacy and Multimorbidity in Hospitalized Patients: Clinical Consequences and Strategies for Medication Optimization

Pavan Kumar Yanamadala P. Rani Sruthi Devarakonda Lakshmi Pujitha Sonti Ruth Rani Annaladasu Kumara Swamy Thetakayala R. Nadendla Pallavi Vadlamudi

Sep 2026 · SN Comprehensive Clinical Medicine · Vol 8 · 0 citations · 48 references

TL;DR

This narrative review summarizes available evidence related to polypharmacy, multimorbidity, medication burden, and medication regimen complexity in hospitalized patients and outlines medication optimization approaches including medication review, deprescribing, medication reconciliation, antimicrobial stewardship, and multidisciplinary medication safety practices in hospital settings.

DOI Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

POLYPHARMACY IN OLDER ADULTS: BALANCING THERAPEUTIC BENEFITS AND MEDICATION-RELATED HARM

This paper focuses on polypharmacy in older adults, defined as the use of five or more medications, and its increasing impact on public health. The aim is to highlight the clinical risks associated with polypharmacy, including adverse drug reactions, drug-related problems, hospital admissions, and mortality. The study...

Bekim Ismaili · INTERNATIONAL CONGRESS FROM... · 0 citations

Review Open access 2026

Deprescribing: A new paradigm in the treatment of older patients

Population aging and the increasing prevalence of chronic diseases have led to an increase in polypharmacy among older patients. Although polypharmacy often represents rational pharmacotherapy, it is associated with an increased risk of adverse drug reactions, drug-drug interactions, reduced medication adherence, and h...

S. Vezmar-Kovačević · Zbornik radova · 0 citations

Review Open access Nov 2026

Artificial Intelligence in Polypharmacy. Moving Beyond Drug Alerts Toward Patient-Specific Medication Safety

Polypharmacy is an increasing challenge in modern clinical practice, particularly among older adults and patients with multimorbidity, chronic kidney disease, heart failure, diabetes, frailty, or cognitive impairment. Its clinical impact extends beyond the number of prescribed medicines and reflects the interaction bet...

Eneida Hoxha, L. Çollaku, Pandush Pojani et al. · Medicus · 0 citations

Review Open access Oct 2026

Prevalence, Patterns, and Risk Factors of Polypharmacy Among Elderly Patients: A Cross-Sectional Study

Polypharmacy is common among older adults because of the increasing prevalence of multimorbidity and chronic diseases requiring long-term pharmacological treatment. Although multiple medicines may be clinically appropriate, increasing medication burden can contribute to medication-related risks and emphasizes the need...

Ravneet Kaur, Satinderpal Singh · International Journal of Dru... · 0 citations

Review Open access Sep 2026

Strategies for developing clinical pharmacy services in ambulatory care: A hematology perspective

Introduction: Patients with hematological malignancies and benign disorders are frequently exposed to high-risk pharmacotherapy requiring close monitoring for toxicity, drug-drug interactions, and medication adherence. Clinical pharmacists are integral members of multidisciplinary teams; however, the organization and i...

Tsvetelina Stefanova, E. Grigorov, G. Petrova et al. · Scripta Scientifica Medica · 0 citations

Review Open access Sep 2026

Polypharmacy and Deprescribing Patterns in an Australian Palliative Care Unit: A Cohort Study.

CONTEXT Polypharmacy is prevalent in palliative care and may increase medication burden, adverse drug events, and clinically significant drug-drug interactions as goals of care shift. OBJECTIVES To identify factors associated with polypharmacy and describe longitudinal medication use and discontinuation patterns in a...

B. Wong, Sam Maleki, Grace Walpole et al. · Journal of Pain and Symptom... · 1 citation